Sanofi S.A.
Records under this name other than the patents Sanofi S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D693,457 | Inhaler now held by Sanofi-Aventis S.A. In force · High confidence | In force | High confidence | |
| US D802,749 | Injection Device now held by Sanofi In force · High confidence | In force | High confidence | |
| US D812,220 | Injection Device now held by Sanofi In force · High confidence | In force | High confidence | |
| US 9,261,476 | Printable Hydrogel for Biosensors now held by Sanofi-Aventis S.A. Term ended Term ended Jun 25, 2025 · Medium confidence | Term ended | Term ended Jun 25, 2025 | Medium confidence |
| US 8,840,930 | Pharmaceutical Composition for Inhalation Lapsed on the fee record Ended Sep 23, 2022 · High confidence | Lapsed on the fee record | Ended Sep 23, 2022 | High confidence |
| US 8,833,365 | Dosing Device for Generating a Gas Flow with a finely Dispersed active substance Lapsed on the fee record Ended Sep 16, 2022 · High confidence | Lapsed on the fee record | Ended Sep 16, 2022 | High confidence |
| US 8,807,132 | Dispersing Unit Lapsed on the fee record Ended Aug 19, 2022 · High confidence | Lapsed on the fee record | Ended Aug 19, 2022 | High confidence |
| US 8,701,660 | Inhaler for Powdery Substances, in particular Medicinal Substances now held by Siegfried Generics International Lapsed on the fee record Ended Apr 22, 2022 · Medium confidence | Lapsed on the fee record | Ended Apr 22, 2022 | Medium confidence |
| US 8,808,201 | Method and Apparatus for Penetrating Tissue now held by Sanofi-Aventis Deutschland GmbH Term ended Term ended Apr 19, 2022 · High confidence | Term ended | Term ended Apr 19, 2022 | High confidence |
| US 9,895,501 | Metering Device for the Inhalation of a Pulverulent Substance Lapsed on the fee record Ended Feb 20, 2022 · Medium confidence | Lapsed on the fee record | Ended Feb 20, 2022 | Medium confidence |